Transforming growth factor-β1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome

Nephron

Volumn 87, Issue 2, 2001, Pages 111-117

  Matsumoto, Koichi ^a   Kanmatsuse, Katsuo ^b  

^a SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IgA nephropathy; Minimal change nephrotic syndrome; Nephrotic syndrome; Transforming growth factor ; Vascular permeability factor

Indexed keywords

CONCANAVALIN A; CYTOKINE; GLUCOCORTICOID; LYMPHOKINE; MONOCLONAL ANTIBODY; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; NEPHROTIC SYNDROME; NEUROPATHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE;

ADULT; CAPILLARY PERMEABILITY; CASE-CONTROL STUDIES; CONCANAVALIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; FEMALE; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; LYMPHOKINES; MALE; NEPHROSIS, LIPOID; PREDNISONE; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035103046     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045898     Document Type: Article

References (24)

1. Vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome
2. Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome
3. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients
4. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome
5. Interleukin-10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis
6. Interleukin-10 and interleukin-13 synergize to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with lipoid nephrosis
7. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome
8. Inflammatory and immunomoduratory roles of TGF-β
9. Effect of transforming growth factor-β on early and late activation events in human T cells
10. Deactivation of macrophages by transforming growth factor-β
11. A critical role for transforming growth factor-β but not interleukin-4 in the suppression of T helper type-1 mediated colitis by CD45RB low CD4+ T cells
12. A retrospective analysis of the natural history of primary IgA nephropathy worldwide
13. Minimal-change nephrosis and allergy
14. Synergy of monocytes and lymphocytes from idiopathic minimal lesion nephrotic patients in relapse in the production of the supernatant factor that increases rat glomerular basement membrane sulfate uptake
15. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse
16. Identification and characterization of specifically expressed genes in mononuclear cells from patients with glomerulosclerosis
17. Modulation of cytokine production by TGF-β
18. Transforming growth factor-β is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells
19. T-helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β
20. Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: A role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii
21. Transforming growth factor-β: The good, the bad, and the ugly
22. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome
23. Regulation of interleukin-3 expression by glucocorticoids in cloned murine T lymphocytes